Clinical Trials Directory

Trials / Completed

CompletedNCT00762164

Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

Comparative Efficacy of a Vytorin 10/80 Tablet Split Into 4 (Estimated Dose Ezetimibe 2.5 + Simvastatin 20) Versus Simvastatin 20 Milligrams on LDL Cholesterol

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Bronx VA Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the efficacy of a Vytorin 10/80 tablet, an approved agent for the treatment of elevated LDL cholesterol which combines the cholesterol absorption inhibitor Ezetimibe 10 mg and simvastatin 80 mg, when split into 4 using a tablet splitter, versus a whole simvastatin 20 milligram tablet.

Conditions

Interventions

TypeNameDescription
DRUGVytorinVytorin 10/80 split into 4
DRUGSimvastatinSimvastatin 20 milligrams

Timeline

Start date
2007-03-01
Primary completion
2009-04-01
Completion
2009-05-01
First posted
2008-09-30
Last updated
2013-07-03
Results posted
2013-07-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00762164. Inclusion in this directory is not an endorsement.